Patient Diagnosed With Clinical Stage T1c Prostate Cancer
After receiving a PSA screening exam, a 65-year-old man is diagnosed with clinical stage T1c prostate cancer. What imaging study is most appropriate to complete his workup?
A 65-year-old man is diagnosed with prostate cancer after receiving a prostate-specific antigen (PSA) screening exam. His initial PSA level is 8.5 ng/mL; 3 out of 12 biopsy cores are involved with Gleason score 3 + 3 = 6 prostate cancer. On exam his prostate is non-enlarged and there is no palpable nodularity (clinical stage T1c).
What imaging study is most appropriate to complete his workup?
